李刚

2017-06-19

Dr. Gary Li is the Founder and CEO of ALSTEM, a company specializing in induced pluripotent stem cell (iPSC) reprogramming technology, stem cell differentiation for drug discovery, and genome editing related products in United States. With 20 years of active research experience Dr. Li is an expert in the fields of stem cell technology, neuroscience, and biochemistry with a successful academic publication record.  He is experienced in the pharmaceutical industry in the United States, and also the owner of several patents on the treatment of neurodegenerative disorders. 

Dr. Li received his PhD degree from Nanjing University in 2000. In 2002, Dr. Li received the research grant from Muscular Dystrophy Association to support his research on Amyotrophic Lateral Sclerosis at SUNY-Albany. In 2006, Dr. Li received the fellowship from California Institute for Regenerative Medicine (CIRM) for his research on stem cell and neuroscience at Gladstone Institute, UCSF. Because of hiscontributions to neurodegenerative study, Dr. Li received the “Kathryn Grupe Award for Excellence in Alzheimer's Research” from the Alzheimer's Association.  I serve as the vice present at the Chinese Stem Cell Foundation. He is also a member of several professional societies. Dr. Li is a joint faculty of Bioengineering Department at Santa Clara University. At present, his company is focusing on applying stem cell and genome editing technologies and providing our products and services to customers all over the world.

 



上一篇:韩丽文
下一篇:冯强
Powered by 飞色网络